Senseonics Holdings, Inc. Common Stock SENS
Analyst Ratings
- Consensus
- Buy — 4 Buy · 1 Hold · 0 Sell (5 analysts)
- Avg. Price Target
- $17.20 (+72.7% upside)
Key Stats
- Today's Range
- $9.90 – $10.19
- 50-Day Range
- $4.79 – $10.64
- 52-Week Range
- $4.79 – $11.58
- Volume
- 606K shs
- Average Volume
- 696K shs
- Market Cap
- $537.73 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 5.95
- Price / Sales
- 11.08
Short Interest
- Short Interest
- 9.24%
- Days to Cover
- 12.55
Financials (TTM)
- Revenue
- $48.55 million
- Net Income
- $-109,391,000
- Net Margin
- -225.34%
- Return on Equity
- -121.12%
- Debt-to-Equity
- 0.62
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
Related Stocks
Compare head-to-head: SENS vs AME·SENS vs MKSI·SENS vs FTV·SENS vs CGNX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.